speb/financial-data huggingface dataset:
Financial ratios for GFG.DE — annual report dated 2022-12-31
Total revenue: 1137446808.5106385
Gross profit: 481595744.6808511
Operating income: -106382978.72340426
Net income: -208829787.23404256
Capital expenditures: 24042553.19148936
Operating cash flow: 98510638.29787235
Depreciation & amortization: 84361702.12765957
Net tangible assets: 297765957.4468085
Owner earnings: -148510638.29787233
Return on net tangible assets (%): -49.87495534119328
Buffett classification: The Gruesome
Stock price: 1.2127659574468084
Shares outstanding: 228364139
Book value: 509361702.1276597
P/B ratio: 0.5437241404761902
Market cap (USD): 276952253.68085104
Debt to equity: 0.7163742690058478
Current ratio: 2.090015519917227
Quick ratio: 1.6497672012415932
Interest coverage ratio: -3.460207612456747
COGS to revenue (%): 57.65993265993266
SG&A to revenue (%): 51.664796109240555
Free cash flow (dilution-adjusted): 16382978.723404255
Buyback yield (%): 0
Retained earnings: -2279361702.12766
Inventory turnover: 3.6222091656874267
Receivables turnover: 28.819407008086255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.701638511367966
FCF margin (%): 1.4403292181069955
Rule of 40 score: 1.4403292181069955
Financial ratios for GFG.DE — annual report dated 2023-12-31
Total revenue: 931111111.111111
Gross profit: 392111111.1111111
Operating income: -136111111.1111111
Net income: -198222222.2222222
Capital expenditures: 4777777.777777778
Operating cash flow: -52777777.777777776
Depreciation & amortization: 64555555.55555555
Net tangible assets: 177666666.66666666
Owner earnings: -138444444.44444445
Return on net tangible assets (%): -77.92370231394622
Buffett classification: The Gruesome
Stock price: 0.2111111111111111
Shares outstanding: 228364139
Book value: 328555555.5555556
P/B ratio: 0.14673380591816026
Market cap (USD): 48210207.12222222
Debt to equity: 0.8096043287115319
Current ratio: 1.8238636363636365
Quick ratio: 1.4750631313131313
Interest coverage ratio: -5.64516129032258
COGS to revenue (%): 57.88782816229118
SG&A to revenue (%): 18.389021479713605
Free cash flow (dilution-adjusted): -86777777.77777778
Buyback yield (%): 0
Retained earnings: -2581222222.2222223
Inventory turnover: 4.390045248868779
Receivables turnover: 21.70984455958549
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.46881878209831
FCF margin (%): -9.319809069212411
Revenue growth (%): -18.14025023901569
Rule of 40 score: -27.4600593082281
Financial ratios for GFG.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 91354166.66666667
Buffett classification: The Gruesome
Stock price: 0.22916666666666669
Shares outstanding: 228364139
Book value: 220000000
P/B ratio: 0.23787931145833335
Market cap (USD): 52333448.520833336
Debt to equity: 0.487689393939394
Current ratio: 1.3152352747614346
Quick ratio: 0.998025666337611
Buyback yield (%): 0
Retained earnings: -2506458333.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GFG.DE — annual report dated 2024-12-31
Total revenue: 752708333.3333334
Gross profit: 337916666.6666667
Operating income: -77604166.66666667
Net income: -85937500
Capital expenditures: 4062500
Operating cash flow: -15625000
Depreciation & amortization: 60520833.333333336
Net tangible assets: 91354166.66666667
Owner earnings: -29479166.666666664
Return on net tangible assets (%): -32.269099201824396
Buffett classification: The Gruesome
Stock price: 0.22916666666666669
Shares outstanding: 228364139
Book value: 220000000
P/B ratio: 0.23787931145833335
Market cap (USD): 52333448.520833336
Debt to equity: 0.487689393939394
Current ratio: 1.3152352747614346
Quick ratio: 0.998025666337611
Interest coverage ratio: -5.912698412698413
COGS to revenue (%): 55.10655964572378
SG&A to revenue (%): 27.52560199280376
Free cash flow (dilution-adjusted): -45729166.66666667
Buyback yield (%): 0
Retained earnings: -2506458333.3333335
Inventory turnover: 4.130705394190872
Receivables turnover: 14.807377049180328
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.33213429256595
FCF margin (%): -6.0752836977580955
Revenue growth (%): -19.160202863961803
Rule of 40 score: -25.2354865617199
Financial ratios for GFG.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 62470588.23529412
Buffett classification: The Gruesome
Stock price: 0.35294117647058826
Shares outstanding: 228364139
Book value: 189647058.82352936
P/B ratio: 0.42499529590570734
Market cap (USD): 80599107.88235295
Debt to equity: 0.5738213399503724
Current ratio: 1.0634642356241235
Quick ratio: 0.7289621318373073
Buyback yield (%): 0
Retained earnings: -2892705882.352941
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRWG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.05
Shares outstanding: 60090905
Market cap (USD): 784186310.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRWG — annual report dated 2022-12-31
Total revenue: 278166000
Gross profit: 70263000
Operating income: -40044000
Net income: -163747000
Capital expenditures: 12896000
Operating cash flow: 11948000
Depreciation & amortization: 17132000
Net tangible assets: 169540000
Owner earnings: -159511000
Return on net tangible assets (%): -94.08458180960245
Buffett classification: The Gruesome
Stock price: 3.92
Shares outstanding: 60090905
Book value: 216396000
P/B ratio: 1.088542984158672
Market cap (USD): 235556347.6
Debt to equity: 0.22569733266788666
Current ratio: 4.768424875677487
Quick ratio: 2.6146840252556296
Interest coverage ratio: -1906.857142857143
COGS to revenue (%): 74.74062250598563
SG&A to revenue (%): 13.214411538433884
Free cash flow (dilution-adjusted): -5915000
Buyback yield (%): 0
Retained earnings: -153603000
Inventory turnover: 2.696851772580457
Receivables turnover: 29.12732984293194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.542135005899521
FCF margin (%): -2.1264281040817354
Rule of 40 score: -2.1264281040817354
Financial ratios for GRWG — annual report dated 2023-12-31
Total revenue: 225882000
Gross profit: 61258000
Operating income: -34185000
Net income: -46496000
Capital expenditures: 6698000
Operating cash flow: 1421000
Depreciation & amortization: 16607000
Net tangible assets: 149690000
Owner earnings: -36587000
Return on net tangible assets (%): -24.441846482730977
Buffett classification: The Gruesome
Stock price: 2.51
Shares outstanding: 60090905
Book value: 173395000
P/B ratio: 0.8698530612186048
Market cap (USD): 150828171.54999998
Debt to equity: 0.2449263242884743
Current ratio: 4.767248625929518
Quick ratio: 2.6688005172971225
Interest coverage ratio: -352.4226804123711
COGS to revenue (%): 72.88053054249563
SG&A to revenue (%): 13.192286237947245
Free cash flow (dilution-adjusted): -8448000
Buyback yield (%): 0
Retained earnings: -200099000
Inventory turnover: 2.53638394576689
Receivables turnover: 24.854973591549296
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.422463489623368
FCF margin (%): -3.740005843759131
Revenue growth (%): -18.795970751278013
Rule of 40 score: -22.535976595037145
Financial ratios for GRWG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.13
Shares outstanding: 60090905
Market cap (USD): 127993627.64999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRWG — annual report dated 2024-12-31
Total revenue: 188866000
Gross profit: 43722000
Operating income: -45097000
Net income: -49510000
Capital expenditures: 1978000
Operating cash flow: -1799000
Depreciation & amortization: 19436000
Net tangible assets: 109709000
Owner earnings: -32052000
Return on net tangible assets (%): -29.215470016133587
Buffett classification: The Gruesome
Stock price: 1.69
Shares outstanding: 60090905
Book value: 120093000
P/B ratio: 0.8456248861299159
Market cap (USD): 101553629.45
Debt to equity: 0.30835269332933646
Current ratio: 4.663755458515284
Quick ratio: 3.0037488671006014
Interest coverage ratio: -644.2428571428571
COGS to revenue (%): 76.85025361896794
SG&A to revenue (%): 15.483464466870691
Free cash flow (dilution-adjusted): -6198000
Buyback yield (%): 5.944642286736114
Retained earnings: -255643000
Inventory turnover: 3.602034991934483
Receivables turnover: 22.438636093620055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.049041165260732
FCF margin (%): -3.2816917814746964
Revenue growth (%): -16.387317271849906
Rule of 40 score: -19.6690090533246
Financial ratios for GRWG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.69
Shares outstanding: 60090905
Market cap (USD): 101553629.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRWG — quarterly report dated 2025-03-31
Total revenue: 35703000
Gross profit: 9707000
Operating income: -9874000
Net income: -9377000
Capital expenditures: 237000
Operating cash flow: -3829000
Depreciation & amortization: 3585000
Net tangible assets: 102313000
Owner earnings: -6029000
Return on net tangible assets (%): -5.892701807199476
Buffett classification: The Gruesome
Stock price: 1.08
Shares outstanding: 60090905
Book value: 111159000
P/B ratio: 0.5838319650230751
Market cap (USD): 64898177.400000006
Debt to equity: 0.3133619410034275
Current ratio: 4.381864161849711
Quick ratio: 2.6907514450867054
COGS to revenue (%): 72.81180853149594
SG&A to revenue (%): 19.919894686721005
Free cash flow (dilution-adjusted): -4569000
Buyback yield (%): 0.09245251932144398
Retained earnings: -265020000
Inventory turnover: 0.6170571340406845
Receivables turnover: 4.467342342342342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.087281079529141
FCF margin (%): -12.797243929081588
Rule of 40 score: -12.797243929081588
Financial ratios for GRWG — quarterly report dated 2025-06-30
Total revenue: 40963000
Gross profit: 11594000
Operating income: -5274000
Net income: -4811000
Capital expenditures: 49000
Operating cash flow: -2921000
Depreciation & amortization: 2687000
Net tangible assets: 98484000
Owner earnings: -2173000
Return on net tangible assets (%): -2.206449778644247
Buffett classification: The Gruesome
Stock price: 0.94
Shares outstanding: 60090905
Book value: 106721000
P/B ratio: 0.5292814975496856
Market cap (USD): 56485450.699999996
Debt to equity: 0.3109978354775536
Current ratio: 3.9972126457859605
Quick ratio: 2.466478398004841
COGS to revenue (%): 71.69640895442228
SG&A to revenue (%): 15.015990039792007
Free cash flow (dilution-adjusted): -3285000
Buyback yield (%): 0.09028873695434637
Retained earnings: -269831000
Inventory turnover: 0.7036682080647867
Receivables turnover: 3.6141697547203107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.9551835853131747
FCF margin (%): -8.019432170495325
Revenue growth (%): 14.73265551914405
Rule of 40 score: 6.713223348648725
Financial ratios for GRWG — quarterly report dated 2025-09-30
Total revenue: 47254000
Gross profit: 12856000
Operating income: -2842000
Net income: -2437000
Capital expenditures: 147000
Operating cash flow: -499000
Depreciation & amortization: 2649000
Net tangible assets: 97999000
Owner earnings: 65000
Buffett classification: The Gruesome
Stock price: 1.87
Shares outstanding: 60090905
Book value: 104704000
P/B ratio: 1.073215849919774
Market cap (USD): 112369992.35000001
Debt to equity: 0.304830761002445
Current ratio: 3.812084427319535
Quick ratio: 2.4418794967095168
COGS to revenue (%): 72.79383755872519
SG&A to revenue (%): 12.075168239725738
Free cash flow (dilution-adjusted): -1067000
Buyback yield (%): 0.0008899172982812791
Retained earnings: -272268000
Inventory turnover: 0.8560123432211826
Receivables turnover: 3.4212279177526788
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1814888162237676
FCF margin (%): -2.2580099039234773
Revenue growth (%): 15.357761882674609
Rule of 40 score: 13.099751978751131
Financial ratios for GRWG — annual report dated 2025-12-31
Total revenue: 161741000
Gross profit: 43275000
Operating income: -25455000
Net income: -24046000
Capital expenditures: 536000
Operating cash flow: -9447000
Depreciation & amortization: 11295000
Net tangible assets: 92093000
Owner earnings: -13287000
Return on net tangible assets (%): -14.427806673688554
Buffett classification: The Gruesome
Stock price: 1.5
Shares outstanding: 60090905
Book value: 97499000
P/B ratio: 0.9244849434353173
Market cap (USD): 90136357.5
Debt to equity: 0.30233130596211244
Current ratio: 3.994109720885467
Quick ratio: 2.5012897016361886
COGS to revenue (%): 73.2442608862317
SG&A to revenue (%): 16.23954346764271
Free cash flow (dilution-adjusted): -11496000
Buyback yield (%): 0
Retained earnings: -279689000
Inventory turnover: 3.0551371982669693
Receivables turnover: 14.473467561521252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.025895180275057
FCF margin (%): -7.107659777050965
Revenue growth (%): -14.362034458293182
Rule of 40 score: -21.469694235344146
Financial ratios for GRWG — quarterly report dated 2025-12-31
Total revenue: 37821000
Gross profit: 9118000
Operating income: -7465000
Net income: -7421000
Capital expenditures: 103000
Operating cash flow: -2198000
Depreciation & amortization: 2374000
Net tangible assets: 92093000
Owner earnings: -5150000
Return on net tangible assets (%): -5.592173129336649
Buffett classification: The Gruesome
Stock price: 1.5
Shares outstanding: 60090905
Book value: 97499000
P/B ratio: 0.9244849434353173
Market cap (USD): 90136357.5
Debt to equity: 0.30233130596211244
Current ratio: 3.994109720885467
Quick ratio: 2.5012897016361886
COGS to revenue (%): 75.89170037809683
SG&A to revenue (%): 19.293514185241005
Free cash flow (dilution-adjusted): -2575000
Buyback yield (%): 0.12425618596802074
Retained earnings: -279689000
Inventory turnover: 0.7402259129358366
Receivables turnover: 3.3844295302013423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.166109114938257
FCF margin (%): -6.8083868750165255
Revenue growth (%): -19.96233123121852
Rule of 40 score: -26.770718106235044
Financial ratios for GSK.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18121621621621622
Shares outstanding: 4005595364
Market cap (USD): 725878835.5572973
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GSK.L — annual report dated 2022-12-31
Total revenue: 35330120481.92771
Gross profit: 23819277108.433735
Operating income: 8107228915.662651
Net income: 18820481927.710846
Capital expenditures: 1201204819.2771084
Operating cash flow: 8919277108.433735
Depreciation & amortization: 2586746987.9518075
Net tangible assets: -12971084337.349398
Owner earnings: 20206024096.385548
Return on net tangible assets (%): -155.7774475199703
Capex to operating income (%): 14.816466042502599
Buffett classification: The Great
Stock price: 0.15084337349397592
P/E ratio: 0.0321042532214839
Shares outstanding: 4005595364
Book value: 12163855421.686737
P/B ratio: 0.049673191320602265
Market cap (USD): 604217517.5575904
Debt to equity: 2.0787440570522997
Current ratio: 0.9105217010083296
Quick ratio: 0.684918895221394
Effective tax rate (%): 12.56218905472637
Interest coverage ratio: 8.146489104116224
COGS to revenue (%): 32.580821170372396
R&D to revenue (%): 18.715045696357933
SG&A to revenue (%): 28.54999317964807
Free cash flow (dilution-adjusted): 5781927710.843373
Buyback yield (%): 0
Retained earnings: 5256626506.0240965
Inventory turnover: 1.8565876408861253
Receivables turnover: 5.378576669112252
Capitalized R&D asset: 6612048192.771085
ROCI (R&D-adjusted, %): 24.256647362849492
FCF margin (%): 16.36543445641795
Rule of 40 score: 16.36543445641795
Financial ratios for GSK.L — annual report dated 2023-12-31
Total revenue: 38389873417.72152
Gross profit: 27548101265.822784
Operating income: 9297468354.43038
Net income: 6718987341.772152
Capital expenditures: 1627848101.2658226
Operating cash flow: 8567088607.594936
Depreciation & amortization: 2903797468.35443
Net tangible assets: -10420253164.556961
Owner earnings: 7994936708.860761
Return on net tangible assets (%): -76.72497570456756
Capex to operating income (%): 17.508509189925118
Buffett classification: The Great
Stock price: 0.16632911392405064
P/E ratio: 0.09915886036729465
Shares outstanding: 4005595364
Book value: 16196202531.645569
P/B ratio: 0.041136008661946076
Market cap (USD): 666247127.632405
Debt to equity: 1.4082063305978898
Current ratio: 0.8849439908866528
Quick ratio: 0.6239794949686729
Effective tax rate (%): 12.467018469656992
Interest coverage ratio: 10.13103448275862
COGS to revenue (%): 28.241229227116854
R&D to revenue (%): 20.518992350303346
SG&A to revenue (%): 30.945001318913214
Free cash flow (dilution-adjusted): 5211392405.063292
Buyback yield (%): 0
Retained earnings: 9163291139.240505
Inventory turnover: 1.5578392142597306
Receivables turnover: 5.135986452159187
Capitalized R&D asset: 12307287479.030045
ROCI (R&D-adjusted, %): 20.46274376454563
Rosenberg metric: 0.5639438867771339
FCF margin (%): 13.574914270640992
Revenue growth (%): 8.660465614202908
Rule of 40 score: 22.2353798848439
Financial ratios for GSK.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18826666666666667
Shares outstanding: 4005595364
Market cap (USD): 754120087.1957333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GSK.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.15849999999999997
Shares outstanding: 4005595364
Market cap (USD): 634886865.1939999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GSK.L — annual report dated 2024-12-31
Total revenue: 39220000000
Gross profit: 27910000000
Operating income: 6927500000
Net income: 3688750000
Capital expenditures: 1667500000
Operating cash flow: 8192500000
Depreciation & amortization: 3188750000
Net tangible assets: -11032500000
Owner earnings: 5210000000
Return on net tangible assets (%): -47.22411058237027
Capex to operating income (%): 24.070732587513533
Buffett classification: The Great
Stock price: 0.15849999999999997
P/E ratio: 0.17211436535249067
Shares outstanding: 4005595364
Book value: 16357500000
P/B ratio: 0.038813196710622035
Market cap (USD): 634886865.1939999
Debt to equity: 1.2980284273269143
Current ratio: 0.7833801908097894
Quick ratio: 0.522099829469512
Effective tax rate (%): 15.127983894161634
Interest coverage ratio: 8.659375
COGS to revenue (%): 28.83732789393167
R&D to revenue (%): 20.400943396226413
SG&A to revenue (%): 35.10645079041305
Free cash flow (dilution-adjusted): 4035000000
Buyback yield (%): 0
Retained earnings: 9745000000
Inventory turnover: 1.5960486858352443
Receivables turnover: 5.640122236203488
Capitalized R&D asset: 15460960080.829649
ROCI (R&D-adjusted, %): 11.859094983664034
Rosenberg metric: 0.04594247147677974
FCF margin (%): 10.288118306986231
Revenue growth (%): 2.162358216829331
Rule of 40 score: 12.450476523815562
Financial ratios for GSK.L — quarterly report dated 2025-03-31
Total revenue: 9761038961.038961
Gross profit: 7245454545.454545
Operating income: 2877922077.9220777
Net income: 2301298701.2987013
Capital expenditures: 268831168.83116883
Operating cash flow: 1487012987.012987
Depreciation & amortization: 1068831168.8311688
Net tangible assets: -11723376623.376623
Owner earnings: 3101298701.2987013
Return on net tangible assets (%): -26.453971419076105
Capex to operating income (%): 9.341155234657041
Buffett classification: The Great
Stock price: 0.18077922077922076
P/E ratio: 0.07866519112144468
Shares outstanding: 4005595364
Book value: 17732467532.467537
P/B ratio: 0.04083630252444703
Market cap (USD): 724128408.6607791
Debt to equity: 1.3499340852497435
Current ratio: 0.8681772358504152
Quick ratio: 0.5801449762373385
Effective tax rate (%): 15.939278937381404
Interest coverage ratio: 13.679012345679011
COGS to revenue (%): 25.771687067589138
R&D to revenue (%): 19.451836083022883
SG&A to revenue (%): 27.541245343267697
Free cash flow (dilution-adjusted): 905194805.1948051
Buyback yield (%): 44.29866539450893
Retained earnings: 10788311688.311687
Inventory turnover: 0.3228333333333333
Receivables turnover: 1.0647400481654627
Capitalized R&D asset: 1898701298.7012987
ROCI (R&D-adjusted, %): 7.718856847945293
FCF margin (%): 9.273549760510909
Rule of 40 score: 9.273549760510909
Financial ratios for GSK.L — quarterly report dated 2025-06-30
Total revenue: 10939726027.39726
Gross profit: 7973972602.739726
Operating income: 2771232876.712329
Net income: 2254794520.547945
Capital expenditures: 343835616.43835616
Operating cash flow: 2871232876.712329
Depreciation & amortization: 1587671232.8767123
Net tangible assets: -10026027397.260275
Owner earnings: 3498630136.9863014
Return on net tangible assets (%): -34.895477524251945
Capex to operating income (%): 12.40731586752348
Buffett classification: The Great
Stock price: 0.1834246575342466
P/E ratio: 0.16126205546880185
Shares outstanding: 4005595364
Book value: 19663013698.630142
P/B ratio: 0.03736583664759649
Market cap (USD): 734724957.8624659
Debt to equity: 1.2090009753378845
Current ratio: 0.8672588085189911
Quick ratio: 0.5692904112277947
Effective tax rate (%): 12.7715951245363
Interest coverage ratio: 10.994565217391305
COGS to revenue (%): 27.109942399198594
R&D to revenue (%): 25.344352617079892
SG&A to revenue (%): 26.79689456548961
Free cash flow (dilution-adjusted): 2004109589.041096
Buyback yield (%): 104.59603181586581
Retained earnings: 12050684931.50685
Inventory turnover: 0.3565546772068511
Receivables turnover: 1.0908345854391477
Capitalized R&D asset: 4044732609.855898
ROCI (R&D-adjusted, %): 6.957043560511996
Rosenberg metric: 0.3836928208683922
FCF margin (%): 18.319559228650135
Revenue growth (%): 12.075426305160862
Rule of 40 score: 30.394985533810996
Financial ratios for GSK.L — quarterly report dated 2025-09-30
Total revenue: 11550000000
Gross profit: 8498648648.648649
Operating income: 3504054054.0540543
Net income: 2897297297.2972975
Capital expenditures: 413513513.5135135
Operating cash flow: 3002702702.7027025
Depreciation & amortization: 997297297.2972974
Net tangible assets: -10586486486.486486
Owner earnings: 3481081081.0810814
Return on net tangible assets (%): -32.88230788869033
Capex to operating income (%): 11.801002699575779
Buffett classification: The Great
Stock price: 0.20729729729729732
P/E ratio: 0.11140555306890766
Shares outstanding: 4005595364
Book value: 21286486486.48649
P/B ratio: 0.039008273796190956
Market cap (USD): 830349093.0237839
Debt to equity: 1.1268410360589132
Current ratio: 0.836317615074529
Quick ratio: 0.5495453267085404
Effective tax rate (%): 12.703583061889251
Interest coverage ratio: 15.52694610778443
COGS to revenue (%): 26.418626418626417
R&D to revenue (%): 19.76131976131976
SG&A to revenue (%): 26.196326196326197
Free cash flow (dilution-adjusted): 1814864864.8648648
Buyback yield (%): 51.59015430707626
Retained earnings: 13535135135.135136
Inventory turnover: 0.36907486106570775
Receivables turnover: 1.0768552349754315
Capitalized R&D asset: 4766647696.620299
ROCI (R&D-adjusted, %): 5.896182526897845
Rosenberg metric: 0.18923592564896932
FCF margin (%): 15.713115713115714
Revenue growth (%): 5.578512396694211
Rule of 40 score: 21.291628109809924
Financial ratios for GSK.L — quarterly report dated 2025-12-31
Total revenue: 11645945945.945946
Gross profit: 8055405405.405405
Operating income: 2035135135.1351352
Net income: 982432432.4324324
Capital expenditures: 756756756.7567568
Operating cash flow: 3078378378.3783784
Depreciation & amortization: -548648648.6486486
Net tangible assets: -9985135135.135136
Owner earnings: -322972972.972973
Capex to operating income (%): 37.18459495351926
Buffett classification: The Good
Stock price: 0.24243243243243245
P/E ratio: 0.11511458135250821
Shares outstanding: 4005595364
Book value: 21562162162.162163
P/B ratio: 0.04503658863760341
Market cap (USD): 971086227.4345946
Debt to equity: 1.1105540235648033
Current ratio: 0.8185685568697116
Quick ratio: 0.5416296573325231
Effective tax rate (%): 23.473684210526315
Interest coverage ratio: 8.655172413793103
COGS to revenue (%): 30.830819215595266
R&D to revenue (%): 27.268507774425622
SG&A to revenue (%): 30.621954049663497
Free cash flow (dilution-adjusted): 1693243243.2432432
Buyback yield (%): 35.068002296786446
Retained earnings: 13795945945.945946
Inventory turnover: 0.44851451721809593
Receivables turnover: 1.4574665990191105
Capitalized R&D asset: 5619864309.514996
ROCI (R&D-adjusted, %): 4.1602572317737385
Rosenberg metric: -0.19419775014801696
FCF margin (%): 14.53933627291715
Revenue growth (%): 0.830700830700829
Rule of 40 score: 15.37003710361798
Financial ratios for GSK.L — annual report dated 2025-12-31
Total revenue: 44144594594.5946
Gross profit: 31959459459.45946
Operating income: 11267567567.567568
Net income: 8498648648.648649
Capital expenditures: 1789189189.1891892
Operating cash flow: 10460810810.81081
Depreciation & amortization: 3127027027.027027
Net tangible assets: -9985135135.135136
Owner earnings: 9836486486.486486
Return on net tangible assets (%): -98.51130058194613
Capex to operating income (%): 15.879107699688175
Buffett classification: The Great
Stock price: 0.24243243243243245
P/E ratio: 0.1142636044365718
Shares outstanding: 4005595364
Book value: 21562162162.162163
P/B ratio: 0.04503658863760341
Market cap (USD): 971086227.4345946
Debt to equity: 1.1105540235648033
Current ratio: 0.8185685568697116
Quick ratio: 0.5416296573325231
Effective tax rate (%): 15.024996622078099
Interest coverage ratio: 12.136826783114993
COGS to revenue (%): 27.602779563473838
R&D to revenue (%): 23.035479229803776
SG&A to revenue (%): 27.820124284446074
Free cash flow (dilution-adjusted): 5921621621.621622
Buyback yield (%): 191.6215839788688
Retained earnings: 13795945945.945946
Inventory turnover: 1.522113436866982
Receivables turnover: 5.524606798579401
Capitalized R&D asset: 18129237431.57715
ROCI (R&D-adjusted, %): 17.759711128912443
Rosenberg metric: 0.506103353783404
FCF margin (%): 13.414148835215967
Revenue growth (%): 12.556335019364093
Rule of 40 score: 25.97048385458006
Financial ratios for GTK.AX — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2661870503597124
Shares outstanding: 112458975
Market cap (USD): 142394097.84172663
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GTK.AX — annual report dated 2022-09-30
Total revenue: 72585632.18390805
Gross profit: 72585632.18390805
Operating income: -1482183.9080459771
Net income: -1908045.9770114943
Capital expenditures: 545402.2988505748
Depreciation & amortization: 6145402.2988505745
Net tangible assets: 13143678.16091954
Owner earnings: 3691954.0229885057
Buffett classification: The Gruesome
Stock price: 0.8831168831168832
Shares outstanding: 112458975
Book value: 91901149.42528737
P/B ratio: 1.0806656946250586
Market cap (USD): 99314419.48051949
Debt to equity: 0.0818095404857793
Current ratio: 1.5581202129040632
Quick ratio: 1.547864468388939
Interest coverage ratio: -3.9615975422427034
COGS to revenue (%): 0
SG&A to revenue (%): 74.6102502790996
Free cash flow (dilution-adjusted): 2860919.540229885
Buyback yield (%): 0
Retained earnings: -21774137.931034483
Inventory turnover: 0
Receivables turnover: 4.283500084788876
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4756030576280497
FCF margin (%): 3.9414405498064116
Rule of 40 score: 3.9414405498064116
Financial ratios for GTK.AX — annual report dated 2023-09-30
Total revenue: 101121428.57142858
Gross profit: 101121428.57142858
Operating income: 8774404.761904763
Net income: 5979761.904761905
Capital expenditures: 1165476.1904761905
Depreciation & amortization: 5030357.142857143
Net tangible assets: 27193452.38095238
Owner earnings: 9844642.857142858
Return on net tangible assets (%): 36.20225456933348
Capex to operating income (%): 13.2826809578726
Buffett classification: The Great
Stock price: 2.858974358974359
P/E ratio: 53.76757989402594
Shares outstanding: 112458975
Book value: 107985714.28571427
P/B ratio: 2.9774061142092467
Market cap (USD): 321517325.9615385
Debt to equity: 0.09538849936058563
Current ratio: 1.7941116168450404
Quick ratio: 1.7857465042850698
Effective tax rate (%): 33.138103161397666
Interest coverage ratio: 37.6045918367347
COGS to revenue (%): 0
SG&A to revenue (%): 69.93889948435402
Free cash flow (dilution-adjusted): 14262500
Buyback yield (%): 0
Retained earnings: -15932738.095238095
Inventory turnover: 0
Receivables turnover: 4.495593955913097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.341172017788936
FCF margin (%): 14.10433001342092
Revenue growth (%): 39.3132849145961
Rule of 40 score: 53.417614928017024
Financial ratios for GTK.AX — annual report dated 2024-09-30
Total revenue: 135822929.93630573
Gross profit: 135822929.93630573
Operating income: 9294267.515923567
Net income: 6080254.777070063
Capital expenditures: 692356.6878980892
Depreciation & amortization: 5728025.477707006
Net tangible assets: 47349044.58598726
Owner earnings: 11115923.566878982
Return on net tangible assets (%): 23.47655304151309
Capex to operating income (%): 7.449287280701753
Buffett classification: The Great
Stock price: 7.23448275862069
P/E ratio: 133.80730668685928
Shares outstanding: 112458975
Book value: 132358598.72611465
P/B ratio: 6.146805145415411
Market cap (USD): 813582515.6896552
Debt to equity: 0.08255414984384249
Current ratio: 1.9026365028066
Quick ratio: 1.8928389181833645
Effective tax rate (%): 34.688013136289
Interest coverage ratio: 37.51156812339332
COGS to revenue (%): 0
SG&A to revenue (%): 68.28063889852842
Free cash flow (dilution-adjusted): 21209554.140127387
Buyback yield (%): 0
Retained earnings: -8926751.592356687
Inventory turnover: 0
Receivables turnover: 4.799072782103795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.37503112808168
FCF margin (%): 15.61559167518594
Revenue growth (%): 34.316664484585715
Rule of 40 score: 49.932256159771654
Financial ratios for GTK.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 47349044.58598726
Buffett classification: The Gruesome
Stock price: 7.23448275862069
Shares outstanding: 112458975
Book value: 132358598.72611465
P/B ratio: 6.146805145415411
Market cap (USD): 813582515.6896552
Debt to equity: 0.08255414984384249
Current ratio: 1.9026365028066
Quick ratio: 1.8928389181833645
Buyback yield (%): 0
Retained earnings: -8926751.592356687
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 84.44
Shares outstanding: 141490692
Market cap (USD): 11947474032.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAS — annual report dated 2022-12-31
Total revenue: 5856700000
Gross profit: 3451900000
Operating income: 429800000
Net income: 203500000
Capital expenditures: 128200000
Operating cash flow: 372900000
Depreciation & amortization: 788100000
Net tangible assets: -1451900000
Owner earnings: 863400000
Return on net tangible assets (%): -59.46690543425856
Capex to operating income (%): 29.827826896230803
Buffett classification: The Good
Stock price: 52.41
P/E ratio: 36.43993694211302
Shares outstanding: 141490692
Book value: 2861900000
P/B ratio: 2.5911202934134665
Market cap (USD): 7415527167.719999
Debt to equity: 1.399909151263147
Current ratio: 1.3696396766680368
Quick ratio: 1.0605562405809015
Effective tax rate (%): 22.37093690248566
Interest coverage ratio: 2.513450292397661
COGS to revenue (%): 41.06066556251814
R&D to revenue (%): 5.2572267659262035
SG&A to revenue (%): 35.06069971144159
Free cash flow (dilution-adjusted): 115300000
Buyback yield (%): 1.6856522425557088
Retained earnings: 4071400000
Inventory turnover: 3.5531914893617023
Receivables turnover: 5.171935711762628
Capitalized R&D asset: 307900000
ROCI (R&D-adjusted, %): 8.565660925353942
FCF margin (%): 1.9686854371915925
Rule of 40 score: 1.9686854371915925
Financial ratios for HAS — annual report dated 2023-12-31
Total revenue: 5003300000
Gross profit: 2869000000
Operating income: 191400000
Net income: -1487800000
Capital expenditures: 135500000
Operating cash flow: 725600000
Depreciation & amortization: 659600000
Net tangible assets: -1804800000
Owner earnings: -963700000
Capex to operating income (%): 70.79414838035528
Buffett classification: The Good
Stock price: 46.15
Shares outstanding: 141490692
Book value: 1087000000
P/B ratio: 6.007171514075437
Market cap (USD): 6529795435.8
Debt to equity: 3.216467341306348
Current ratio: 1.1299358101536665
Quick ratio: 0.9684886208908773
Interest coverage ratio: 1.0273752012882447
COGS to revenue (%): 42.65784582175764
R&D to revenue (%): 6.133951591949313
SG&A to revenue (%): 36.75174384905962
Free cash flow (dilution-adjusted): 443900000
Buyback yield (%): 0
Retained earnings: 2188400000
Inventory turnover: 6.428614457831325
Receivables turnover: 4.860876323715146
Capitalized R&D asset: 513193000
ROCI (R&D-adjusted, %): 5.87004177060629
Rosenberg metric: -1.893147125690159
FCF margin (%): 8.872144384706095
Revenue growth (%): -14.57134563832875
Rule of 40 score: -5.699201253622656
Financial ratios for HAS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.73
Shares outstanding: 141490692
Market cap (USD): 9583164569.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAS — annual report dated 2024-12-31
Total revenue: 4135500000
Gross profit: 2671800000
Operating income: 727400000
Net income: 394400000
Capital expenditures: 87200000
Operating cash flow: 847400000
Depreciation & amortization: 212300000
Net tangible assets: -1639000000
Owner earnings: 519500000
Return on net tangible assets (%): -31.69615619280049
Capex to operating income (%): 11.987902117129503
Buffett classification: The Great
Stock price: 52.96
P/E ratio: 18.99935864178499
Shares outstanding: 141490692
Book value: 1185000000
P/B ratio: 6.323499618835442
Market cap (USD): 7493347048.32
Debt to equity: 2.878143459915612
Current ratio: 1.600299721687005
Quick ratio: 1.4046242774566473
Effective tax rate (%): 20.643863179074444
Interest coverage ratio: 4.248831775700935
COGS to revenue (%): 35.39354370692782
R&D to revenue (%): 7.111594728569702
SG&A to revenue (%): 37.0620239390642
Free cash flow (dilution-adjusted): 599100000
Buyback yield (%): 0
Retained earnings: 2274200000
Inventory turnover: 5.338074398249453
Receivables turnover: 4.496086105675147
Capitalized R&D asset: 601330000
ROCI (R&D-adjusted, %): 12.969143233946953
Rosenberg metric: -0.642554578038449
FCF margin (%): 14.486760972071092
Revenue growth (%): -17.344552595287112
Rule of 40 score: -2.85779162321602
Financial ratios for HAS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.96
Shares outstanding: 141490692
Market cap (USD): 7493347048.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAS — quarterly report dated 2025-03-31
Total revenue: 887100000
Gross profit: 625600000
Operating income: 195700000
Net income: 99500000
Capital expenditures: 13800000
Operating cash flow: 138100000
Depreciation & amortization: 41600000
Net tangible assets: -1611600000
Owner earnings: 127300000
Return on net tangible assets (%): -7.8989823777612305
Capex to operating income (%): 7.051609606540624
Buffett classification: The Great
Stock price: 58.88
P/E ratio: 20.93209031396985
Shares outstanding: 141490692
Book value: 1197500000
P/B ratio: 6.956970308943633
Market cap (USD): 8330971944.96
Debt to equity: 2.806096033402923
Current ratio: 1.6546712802768166
Quick ratio: 1.3987889273356402
Effective tax rate (%): 27.159590043923863
Interest coverage ratio: 4.704326923076923
COGS to revenue (%): 29.478074625183183
R&D to revenue (%): 9.074512456318342
SG&A to revenue (%): 36.63623041370759
Free cash flow (dilution-adjusted): 76500000
Buyback yield (%): 0
Retained earnings: 2274400000
Inventory turnover: 0.8840432724814064
Receivables turnover: 1.3510508681084374
Capitalized R&D asset: 80500000
ROCI (R&D-adjusted, %): 5.0229966092590725
FCF margin (%): 8.623605005072708
Rule of 40 score: 8.623605005072708
Financial ratios for HAS — quarterly report dated 2025-06-30
Total revenue: 980800000
Gross profit: 671000000
Operating income: 223700000
Net income: -854700000
Capital expenditures: 16100000
Operating cash flow: 71300000
Depreciation & amortization: 38300000
Net tangible assets: -1505100000
Owner earnings: -832500000
Capex to operating income (%): 7.1971390254805545
Buffett classification: The Great
Stock price: 71.42
Shares outstanding: 141490692
Book value: 269700000
P/B ratio: 37.46853994304783
Market cap (USD): 10105265222.64
Debt to equity: 12.416759362254357
Current ratio: 1.6624857468643102
Quick ratio: 1.3227724385079003
Interest coverage ratio: 5.509852216748769
COGS to revenue (%): 31.58646003262643
R&D to revenue (%): 7.9017128874388245
SG&A to revenue (%): 35.31810766721044
Free cash flow (dilution-adjusted): 9900000
Buyback yield (%): 0
Retained earnings: 1319300000
Inventory turnover: 0.742747542555742
Receivables turnover: 1.3663973251602117
Capitalized R&D asset: 131435000
ROCI (R&D-adjusted, %): 6.094438457083702
Rosenberg metric: 0.5639751552795031
FCF margin (%): 1.0093800978792822
Revenue growth (%): 10.562507045428926
Rule of 40 score: 11.571887143308208
Financial ratios for HAS — quarterly report dated 2025-09-30
Total revenue: 1387500000
Gross profit: 858900000
Operating income: 341100000
Net income: 233900000
Capital expenditures: 19700000
Operating cash flow: 280600000
Depreciation & amortization: 48200000
Net tangible assets: -1321000000
Owner earnings: 262400000
Return on net tangible assets (%): -19.863739591218774
Capex to operating income (%): 5.775432424508942
Buffett classification: The Great
Stock price: 74.03
P/E ratio: 11.195549303933305
Shares outstanding: 141490692
Book value: 433800000
P/B ratio: 24.146048706224068
Market cap (USD): 10474555928.76
Debt to equity: 7.7139234670355
Current ratio: 1.7048670062252405
Quick ratio: 1.4242359932088284
Effective tax rate (%): 23.36173001310616
Interest coverage ratio: 8.360294117647058
COGS to revenue (%): 38.097297297297295
R&D to revenue (%): 7.034234234234233
SG&A to revenue (%): 28.511711711711712
Free cash flow (dilution-adjusted): 199900000
Buyback yield (%): 0
Retained earnings: 1452400000
Inventory turnover: 1.3324930678094278
Receivables turnover: 1.3941921221864952
Capitalized R&D asset: 176090000
ROCI (R&D-adjusted, %): 8.251075440738138
Rosenberg metric: 2.424516129032258
FCF margin (%): 14.407207207207207
Revenue growth (%): 41.46615008156607
Rule of 40 score: 55.87335728877328
Financial ratios for HAS — quarterly report dated 2025-12-31
Total revenue: 1445900000
Gross profit: 880700000
Operating income: 297500000
Net income: 203100000
Capital expenditures: 13700000
Operating cash flow: 403200000
Depreciation & amortization: 43200000
Net tangible assets: -1174900000
Owner earnings: 232600000
Return on net tangible assets (%): -19.797429568473913
Capex to operating income (%): 4.605042016806723
Buffett classification: The Great
Stock price: 80.78
P/E ratio: 14.068953840177253
Shares outstanding: 141490692
Book value: 565500000
P/B ratio: 20.211526259522547
Market cap (USD): 11429618099.76
Debt to equity: 5.827586206896552
Current ratio: 1.380845491956603
Quick ratio: 1.241996686441131
Effective tax rate (%): 25.027685492801773
Interest coverage ratio: 7.3638613861386135
COGS to revenue (%): 39.0898402379141
R&D to revenue (%): 8.990939899024829
SG&A to revenue (%): 29.31046407082094
Free cash flow (dilution-adjusted): 328200000
Buyback yield (%): 0
Retained earnings: 1554100000
Inventory turnover: 2.1755196304849886
Receivables turnover: 1.364314021513493
Capitalized R&D asset: 220967000
ROCI (R&D-adjusted, %): 8.34984893129366
Rosenberg metric: 0.22336065573770492
FCF margin (%): 22.698665191230376
Revenue growth (%): 4.2090090090090095
Rule of 40 score: 26.907674200239384
Financial ratios for HAS — annual report dated 2025-12-31
Total revenue: 4701300000
Gross profit: 3036200000
Operating income: 1058000000
Net income: -318200000
Capital expenditures: 63300000
Operating cash flow: 893200000
Depreciation & amortization: 171300000
Net tangible assets: -1174900000
Owner earnings: -210200000
Capex to operating income (%): 5.982986767485822
Buffett classification: The Great
Stock price: 80.78
Shares outstanding: 141490692
Book value: 565500000
P/B ratio: 20.211526259522547
Market cap (USD): 11429618099.76
Debt to equity: 5.827586206896552
Current ratio: 1.380845491956603
Quick ratio: 1.241996686441131
Interest coverage ratio: 6.4749082007343945
COGS to revenue (%): 35.4178631442367
R&D to revenue (%): 8.201986684534065
SG&A to revenue (%): 31.71037798055857
Free cash flow (dilution-adjusted): 614500000
Buyback yield (%): 0
Retained earnings: 1554100000
Inventory turnover: 6.409160892994612
Receivables turnover: 4.436025665219852
Capitalized R&D asset: 683924000
ROCI (R&D-adjusted, %): 25.53902135191094
Rosenberg metric: 1.2390343420605237
FCF margin (%): 13.070852742858358
Revenue growth (%): 13.681537903518318
Rule of 40 score: 26.752390646376675
Financial ratios for HI91.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 154.86363636363637
Shares outstanding: 227648372
Market cap (USD): 35254454700.18182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HI91.DE — annual report dated 2022-12-31
Total revenue: 8773000000
Gross profit: 2698000000
Operating income: 2094000000
Net income: 1257000000
Capital expenditures: 102000000
Operating cash flow: 1681000000
Depreciation & amortization: 162000000
Net tangible assets: -12022000000
Owner earnings: 1317000000
Return on net tangible assets (%): -10.954915987356513
Capex to operating income (%): 4.871060171919771
Buffett classification: The Great
Stock price: 125.31914893617022
P/E ratio: 22.695863353814385
Shares outstanding: 227648372
Book value: -1098000000
Market cap (USD): 28528700235.744682
Debt to equity: -8.826047358834245
Current ratio: 0.8511269276393831
Quick ratio: 0.8511269276393831
Effective tax rate (%): 27.508650519031143
Interest coverage ratio: 5.04578313253012
COGS to revenue (%): 69.24655192066568
SG&A to revenue (%): 4.354268779208937
Free cash flow (dilution-adjusted): 1417000000
Buyback yield (%): 5.5733348763215975
Retained earnings: -5190000000
Receivables turnover: 6.611152976639035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.248764415156508
FCF margin (%): 16.15182947680383
Rule of 40 score: 16.15182947680383
Financial ratios for HI91.DE — annual report dated 2023-12-31
Total revenue: 10235000000
Gross profit: 2930000000
Operating income: 2263000000
Net income: 1151000000
Capital expenditures: 247000000
Operating cash flow: 1946000000
Depreciation & amortization: 147000000
Net tangible assets: -13495000000
Owner earnings: 1051000000
Return on net tangible assets (%): -7.788069655427936
Capex to operating income (%): 10.914714980114892
Buffett classification: The Great
Stock price: 149.23333333333332
P/E ratio: 29.51583438876339
Shares outstanding: 227648372
Book value: -2347000000
Market cap (USD): 33972725381.466663
Debt to equity: -4.311887515977844
Current ratio: 0.7023105857066093
Quick ratio: 0.7023105857066093
Effective tax rate (%): 31.97399527186761
Interest coverage ratio: 4.877155172413793
COGS to revenue (%): 71.37274059599413
SG&A to revenue (%): 3.986321446018564
Free cash flow (dilution-adjusted): 1530000000
Buyback yield (%): 6.881991284913111
Retained earnings: -4207000000
Receivables turnover: 6.882985877605918
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.376658960527443
FCF margin (%): 14.948705422569613
Revenue growth (%): 16.66476689843839
Rule of 40 score: 31.613472321008004
Financial ratios for HI91.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 149.23333333333332
Shares outstanding: 227648372
Market cap (USD): 33972725381.466663
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HI91.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 139.90625
Shares outstanding: 227648372
Market cap (USD): 31849430045.125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HI91.DE — annual report dated 2024-12-31
Total revenue: 11174000000
Gross profit: 3063000000
Operating income: 2365000000
Net income: 1539000000
Capital expenditures: 198000000
Operating cash flow: 2013000000
Depreciation & amortization: 146000000
Net tangible assets: -15181000000
Owner earnings: 1487000000
Return on net tangible assets (%): -9.795138660167314
Capex to operating income (%): 8.372093023255815
Buffett classification: The Great
Stock price: 139.90625
P/E ratio: 20.694886319119558
Shares outstanding: 227648372
Book value: -3689000000
Market cap (USD): 31849430045.125
Debt to equity: -3.222011385199241
Current ratio: 0.6961702127659575
Quick ratio: 0.6961702127659575
Effective tax rate (%): 13.684800897363994
Interest coverage ratio: 4.156414762741652
COGS to revenue (%): 72.58815106497227
SG&A to revenue (%): 3.713978879541793
Free cash flow (dilution-adjusted): 1639000000
Buyback yield (%): 9.083365058342116
Retained earnings: -2822000000
Receivables turnover: 7.058749210360076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.00507528336999
FCF margin (%): 14.66797923751566
Revenue growth (%): 9.174401563263313
Rule of 40 score: 23.842380800778972
Financial ratios for HI91.DE — quarterly report dated 2025-03-31
Total revenue: 2695000000
Gross profit: 697000000
Operating income: 536000000
Net income: 300000000
Capital expenditures: 40000000
Operating cash flow: 452000000
Depreciation & amortization: 41000000
Net tangible assets: -15859000000
Owner earnings: 301000000
Return on net tangible assets (%): -1.8979759127309415
Capex to operating income (%): 7.462686567164178
Buffett classification: The Great
Stock price: 145.9891304347826
P/E ratio: 27.69515656097826
Shares outstanding: 227648372
Book value: -4339000000
Market cap (USD): 33234187873.17391
Debt to equity: -2.7379580548513482
Current ratio: 0.571664943123061
Quick ratio: 0.571664943123061
Effective tax rate (%): 26.82926829268293
Interest coverage ratio: 3.696551724137931
COGS to revenue (%): 74.13729128014842
SG&A to revenue (%): 3.4879406307977736
Free cash flow (dilution-adjusted): 376000000
Buyback yield (%): 2.632830997222248
Retained earnings: -2559000000
Receivables turnover: 1.711111111111111
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.782298358315489
FCF margin (%): 13.951762523191094
Rule of 40 score: 13.951762523191094
Financial ratios for HI91.DE — quarterly report dated 2025-06-30
Total revenue: 3137000000
Gross profit: 956000000
Operating income: 778000000
Net income: 442000000
Capital expenditures: 43000000
Operating cash flow: 658000000
Depreciation & amortization: 43000000
Net tangible assets: -16155000000
Owner earnings: 442000000
Return on net tangible assets (%): -2.7359950479727635
Capex to operating income (%): 5.526992287917738
Buffett classification: The Great
Stock price: 158.01176470588237
P/E ratio: 48.47859971986682
Shares outstanding: 227648372
Book value: -4549000000
Market cap (USD): 35971120992.14118
Debt to equity: -2.5704550450648496
Current ratio: 0.538495092693566
Quick ratio: 0.538495092693566
Effective tax rate (%): 29.72972972972973
Interest coverage ratio: 5.152317880794702
COGS to revenue (%): 69.52502390819254
SG&A to revenue (%): 3.4746573159069176
Free cash flow (dilution-adjusted): 560000000
Buyback yield (%): 2.137826063769344
Retained earnings: -2155000000
Receivables turnover: 1.8717183770883055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.8733987101334035
FCF margin (%): 17.851450430347466
Revenue growth (%): 16.400742115027832
Rule of 40 score: 34.252192545375294